Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO)
If you are the contact person for this centre and you wish to make any changes, please contact us.
Professor of Genetics at the University of Valencia and researcher of the Genomics and Health Area at the Foundation for the Promotion of Health and Biomedical Research of the Valencian Community (Fisabio)
Professor of Genetics at the University of Valencia and researcher at the mixed unit Infection and Public Health FISABIO/Universitat de Valencia
Senior Researcher at FISABIO-Dr. Peset University Hospital
Epidemiologist, researcher in the Health Services and Pharmacoepidemiology Research Area of the Foundation for the Promotion of Health and Biomedical Research of the Valencian Community (FISABIO) and Director of Gaceta Sanitaria, the scientific journal of the Spanish Society of Public Health and Health Administration (SESPAS)
A clinical trial in Brazil evaluated the effectiveness of a depression drug versus placebo in reducing the risk of hospitalisation for SARS-CoV-2 infection. Administration of 100 mg twice daily for ten days to high-risk outpatients with early diagnosis reduces the need for hospitalisation.